Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Romin Nabiey, Chief Accounting Officer of GoodRx Holdings, Inc., reported the vesting and subsequent withholding of shares to cover tax obligations related to restricted stock units.

Summary

  • On March 8, 2025, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., engaged in transactions involving Class A Common Stock.
  • These transactions included the vesting of 10,201 and 2,233 restricted stock units, which converted into Class A Common Stock.
  • Following the vesting, 4,191 and 808 shares were withheld to satisfy tax obligations at a price of $4.61 per share.
  • After these transactions, Nabiey directly owns 106,874 shares of Class A Common Stock and holds 26,787 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting standard executive compensation practices; it doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track executive compensation and ownership changes.

Stakeholder Impact

  • The transactions have a minor impact on the total outstanding shares of GoodRx Holdings, Inc.

Key Dates

DateDescription
December 8, 2022Initial vesting date for a portion of the restricted stock unit award.
June 8, 2024Vesting date for a portion of the restricted stock unit award.
03/08/2025Date of the reported transactions: vesting of restricted stock units and withholding of shares for taxes.
03/10/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.